154 related articles for article (PubMed ID: 33439527)
1. Development of toxic epidermal necrolysis in a coronavirus disease 2019 patient with recurrence of positive SARS-CoV-2 viral RNA.
Tanaka A; Isei M; Kikuzawa C; Hinogami H; Nishida K; Gohma I; Ogawa Y
J Dermatol; 2021 Mar; 48(3):e144-e145. PubMed ID: 33439527
[No Abstract] [Full Text] [Related]
2. COVID-19-induced toxic epidermal necrolysis.
Narang I; Panthagani AP; Lewis M; Chohan B; Ferguson A; Nambi R
Clin Exp Dermatol; 2021 Jul; 46(5):927-929. PubMed ID: 33511662
[No Abstract] [Full Text] [Related]
3. Granuloma annulare triggered by SARS-CoV-2 infection. The first reported case.
García-Gil MF; Monte Serrano J; García García M; Matovelle Ochoa C; Ara-Martín M
J Dermatol; 2021 Jan; 48(1):e1-e2. PubMed ID: 33169426
[No Abstract] [Full Text] [Related]
4. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Eginli A; Shah K; Watkins C; Krishnaswamy G
Ann Allergy Asthma Immunol; 2017 Feb; 118(2):143-147. PubMed ID: 28153080
[No Abstract] [Full Text] [Related]
5. Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with intravenous immunoglobulin: 'Killing 2 birds with one stone'.
Saha M; D'Cruz A; Paul N; Healy R; Collins D; Charles DA; Sahu S; Fonia A
J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):e97-e98. PubMed ID: 32805059
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.
Olagunju A; Fowotade A; Olagunoye A; Ojo TO; Adefuye BO; Fagbamigbe AF; Adebiyi AO; Olagunju OI; Ladipo OT; Akinloye A; Adeagbo BA; Onayade A; Bolaji OO; Happi C; Rannard S; Owen A
Trials; 2021 Jan; 22(1):3. PubMed ID: 33397457
[TBL] [Abstract][Full Text] [Related]
7. Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
Pezzarossa E; Ungari M; Caresana G; Sagradi F; Cimardi L; Pan A; Testa S; Aguggini S; Varotti E; Tanzi G; Manotti L; Ferrero G; Gusolfino MD; Trombatore M;
Am J Dermatopathol; 2021 May; 43(5):342-348. PubMed ID: 33405402
[TBL] [Abstract][Full Text] [Related]
8. Stevens-Johnson syndrome associated with radiation recall dermatitis in a patient treated with immune checkpoint inhibitor.
Horii M; Kobayashi T; Maeda S; Takehara K; Matsushita T
J Dermatol; 2019 Nov; 46(11):e434-e436. PubMed ID: 31342541
[No Abstract] [Full Text] [Related]
9. [Toxic epidermal necrolysis].
Lewerenz V; Bruch-Gerharz D; Ruzicka T; Kruse R
Hautarzt; 2006 Apr; 57(4):322-4. PubMed ID: 16523274
[No Abstract] [Full Text] [Related]
10. Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findings.
Nuno-Gonzalez A; Martin-Carrillo P; Magaletsky K; Martin Rios MD; Herranz Mañas C; Artigas Almazan J; García Casasola G; Perez Castro E; Gallego Arenas A; Mayor Ibarguren A; Feito Rodríguez M; Lozano Masdemont B; Beato M; Ruiz Bravo E; Oliver P; Montero Vega MD; Herranz Pinto P
Br J Dermatol; 2021 Jan; 184(1):184-185. PubMed ID: 32969503
[No Abstract] [Full Text] [Related]
11. Acute management of Stevens-Johnson syndrome and toxic epidermal necrolysis to minimize ocular sequelae.
Tseng SC
Am J Ophthalmol; 2009 Jun; 147(6):949-51. PubMed ID: 19463535
[No Abstract] [Full Text] [Related]
12. Systemic and local management at the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
Sotozono C; Ueta M; Kinoshita S
Am J Ophthalmol; 2010 Feb; 149(2):354; author reply 355. PubMed ID: 20103059
[No Abstract] [Full Text] [Related]
13. COVID-19 pneumonia in kidney transplant recipients-Where we are?
Machado DJB; Ianhez LE
Transpl Infect Dis; 2020 Oct; 22(5):e13306. PubMed ID: 32364677
[TBL] [Abstract][Full Text] [Related]
14. Toxic epidermal necrolysis.
Stabenow DL
Postgrad Med; 1972 Dec; 52(6):89-92. PubMed ID: 4635614
[No Abstract] [Full Text] [Related]
15. Pyrexia by COVID-19 in a patient treated with dabrafenib/trametinib therapy.
Hashimoto H; Ito T; Ide T; Sasaki N; Hikichi S; Furue M
J Dermatol; 2021 Feb; 48(2):e122-e123. PubMed ID: 33200424
[No Abstract] [Full Text] [Related]
16. Challenges in the treatment of a patient with toxic epidermal necrolysis associated with COVID-19: A case report.
Emadi SN; Hamzelou S; Saffarian Z; Shakoei S
Dermatol Ther; 2021 Jan; 34(1):e14656. PubMed ID: 33301196
[No Abstract] [Full Text] [Related]
17. A Convalescent of COVID-19 with RT-PCR Test Continues Positive in Stool.
Yang Z; Yu M; Li G; Dai X; Liu G; Xie J; Li G; Jie Y
Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337843
[TBL] [Abstract][Full Text] [Related]
18. Alopecia Areata-like Hair Loss Accompanying Toxic Epidermal Necrolysis.
Mashima E; Sawada Y; Inoue A; Saito-Sasaki N; Yamaguchi T; Yoshioka H; Ohmori S; Haruyama S; Yoshioka M; Okada E; Nakamura M
Acta Derm Venereol; 2018 Oct; 98(9):906-907. PubMed ID: 29856464
[No Abstract] [Full Text] [Related]
19. Methazolamide-induced toxic epidermal necrolysis in a Chinese woman with HLA-B5901.
Xu Y; Wu M; Sheng F; Sun Q
Indian J Ophthalmol; 2015 Jul; 63(7):623-4. PubMed ID: 26458485
[No Abstract] [Full Text] [Related]
20. COVID-19 vaccine-induced Stevens-Johnson syndrome.
Dash S; Sirka CS; Mishra S; Viswan P
Clin Exp Dermatol; 2021 Dec; 46(8):1615-1617. PubMed ID: 34081806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
